Enliven Therapeutics, Inc. (ELVN)
47.54
-1.26
(-2.58%)
USD |
NASDAQ |
Nov 16, 16:00
47.54
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Price to Book Value : 3.988 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.093 |
| November 12, 2026 | 4.052 |
| November 11, 2026 | 4.294 |
| November 10, 2026 | 4.295 |
| November 09, 2026 | 4.324 |
| November 06, 2026 | 4.146 |
| November 05, 2026 | 3.757 |
| November 04, 2026 | 3.963 |
| November 03, 2026 | 3.760 |
| November 02, 2026 | 3.744 |
| October 30, 2026 | 3.712 |
| October 29, 2026 | 3.781 |
| October 28, 2026 | 3.756 |
| October 27, 2026 | 3.665 |
| October 26, 2026 | 3.480 |
| October 23, 2026 | 3.483 |
| October 22, 2026 | 3.517 |
| October 21, 2026 | 3.508 |
| October 20, 2026 | 3.46 |
| October 19, 2026 | 3.246 |
| October 16, 2026 | 3.130 |
| October 15, 2026 | 3.299 |
| October 14, 2026 | 3.295 |
| October 13, 2026 | 3.312 |
| October 12, 2026 | 3.426 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.437 |
| October 08, 2026 | 3.408 |
| October 07, 2026 | 3.469 |
| October 06, 2026 | 3.556 |
| October 05, 2026 | 3.814 |
| October 02, 2026 | 3.940 |
| October 01, 2026 | 3.876 |
| September 30, 2026 | 3.845 |
| September 29, 2026 | 3.806 |
| September 28, 2026 | 3.765 |
| September 25, 2026 | 3.662 |
| September 24, 2026 | 3.696 |
| September 23, 2026 | 3.772 |
| September 22, 2026 | 3.944 |
| September 21, 2026 | 3.999 |
| September 18, 2026 | 4.047 |
| September 17, 2026 | 4.111 |
| September 16, 2026 | 4.020 |
| September 15, 2026 | 4.366 |
| September 14, 2026 | 4.454 |
| September 11, 2026 | 4.445 |
| September 10, 2026 | 4.601 |
| September 09, 2026 | 4.701 |
| September 08, 2026 | 4.858 |
| September 04, 2026 | 4.854 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Definium Therapeutics, Inc. | 4.262 |
| Cocrystal Pharma, Inc. | 12.94 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8618 |
Price to Book Value Related Metrics
| Price | 47.54 |
| Earnings Yield | -3.57% |
| Market Cap | 3.497B |